To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NCAPHTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
346 supporting clones for gene NCAPH back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI560881 testis NCAPH.a 1 to 678 1 to 678   tiling clone,   678/682
(99 %)
7 diff
(99.0 %id)
TI_44349118   NCAPH.a 2 to 678 78 to 754       677/758
(89 %)
8 diff
(99.0 %id)
NM_015341.3   NCAPH.a 11 to 4505 1 to 4495 exact RefSeq,   4495/4495
(100 %)
0 diff
(100 %id)
TI_44348133   NCAPH.a 17 to 715 87 to 785       699/785
(89 %)
8 diff
(99.0 %id)
BI559873 testis NCAPH.a 18 to 715 1 to 698       698/698
(100 %)
6 diff
(99.2 %id)
BG723419 testis NCAPH.a 20 to 689 1 to 671       671/677
(99 %)
12 diff
(98.3 %id)
BG718876 testis NCAPH.a 22 to 744 1 to 724       724/724
(100 %)
6 diff
(99.2 %id)
AL710142 human skeletal muscle NCAPH.a 24 to 711 1 to 688       688/688
(100 %)
2 diff
(99.8 %id)
BI562185 testis NCAPH.a 24 to 689 1 to 667       667/823
(81 %)
13 diff
(98.5 %id)
DB010230 colon, tumor tissue NCAPH.a 24 to 607 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BG700591 brain, hippocampus NCAPH.a 25 to 764 6 to 744       741/744
(99 %)
20 diff
(97.4 %id)
TI_44350163   NCAPH.a 25 to 689 121 to 786       666/942
(70 %)
17 diff
(98.2 %id)
DB458762 testis NCAPH.a 30 to 477 1 to 449       449/449
(100 %)
4 diff
(99.2 %id)
BG529521 embryonal carcinoma, testis NCAPH.a 30 to 818 1 to 793       791/818
(96 %)
21 diff
(97.5 %id)
BP233540 coronary artery NCAPH.a 31 to 617 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BP365720 lung NCAPH.a 31 to 611 1 to 581       581/583
(99 %)
1 diff
(99.9 %id)
DA474593   NCAPH.a 32 to 590 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA615303   NCAPH.a 32 to 619 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB068604 testis NCAPH.a 32 to 495 2 to 466   capped   465/465
(100 %)
6 diff
(98.8 %id)
DB124398 thymus NCAPH.a 32 to 576 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB131125 thymus NCAPH.a 32 to 581 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BG719484 testis NCAPH.a 34 to 625 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
DB445103 testis NCAPH.a 36 to 468 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
DA614118   NCAPH.a 40 to 618 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BC024211 Placenta, choriocarcinoma NCAPH.a 52 to 2808 1 to 2757 V539A available from MGC, AAA   2757/2757
(100 %)
3 diff
(99.9 %id)
DB451646 testis NCAPH.a 57 to 556 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
DB022562 testis NCAPH.a 60 to 630 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB150494 thymus NCAPH.a 62 to 628 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
AK291053   NCAPH.a 65 to 2388 1 to 2324 L131S V539A     2324/2324
(100 %)
3 diff
(99.9 %id)
DB456576 testis NCAPH.a 65 to 555 1 to 491       491/491
(100 %)
0 diff
(100 %id)
DA700942   NCAPH.a 65 to 584 2 to 522   capped   521/521
(100 %)
2 diff
(99.7 %id)
DA738443   NCAPH.a 65 to 796 2 to 732   capped   731/731
(100 %)
5 diff
(99.4 %id)
DA007905   NCAPH.a 66 to 605 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA613032   NCAPH.a 66 to 660 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
DA613318   NCAPH.a 66 to 589 2 to 526   capped   525/525
(100 %)
2 diff
(99.7 %id)
DA726000   NCAPH.a 66 to 629 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BM834085 stomach NCAPH.a 66 to 640 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DB134741 thymus NCAPH.a 66 to 624 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA027322   NCAPH.a 67 to 629 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA435234 tongue, tumor tissue NCAPH.a 67 to 635 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA475585   NCAPH.a 67 to 630 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA664542   NCAPH.a 67 to 838 2 to 772   capped   771/772
(99 %)
4 diff
(99.5 %id)
AU131710   NCAPH.a 67 to 831 2 to 766   capped   765/765
(100 %)
1 diff
(99.9 %id)
DA760361   NCAPH.a 67 to 646 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA902598   NCAPH.a 67 to 625 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA907200   NCAPH.a 67 to 625 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
T85017 liver and spleen NCAPH.a 68 to 367 1 to 303       303/320
(94 %)
7 diff
(97.9 %id)
CN340542 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells NCAPH.a 69 to 798 4 to 733       730/733
(99 %)
5 diff
(99.4 %id)
CN340549 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 NCAPH.a 71 to 777 1 to 707       707/707
(100 %)
2 diff
(99.8 %id)
BE280158 choriocarcinoma, placenta NCAPH.a 71 to 777 1 to 705       705/705
(100 %)
12 diff
(98.3 %id)
CN340547 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 72 to 722 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
BF695885 brain, primitive neuroectoderm NCAPH.a 72 to 650 1 to 581       581/618
(94 %)
62 diff
(90.0 %id)
BF698460 brain, primitive neuroectoderm NCAPH.a 72 to 1043 1 to 631       539/862
(62 %)
28 diff
(96.8 %id)
DA679741   NCAPH.a 72 to 640 2 to 570   capped   569/572
(99 %)
1 diff
(99.9 %id)
DN996038 breast cancer, Mammary gland (cancer tissue) NCAPH.a 72 to 795 1 to 723       723/723
(100 %)
9 diff
(98.8 %id)
DA484071 brain NCAPH.a 73 to 627 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BG387764 embryonal carcinoma, cell line, testis NCAPH.a 74 to 689 1 to 619       617/1080
(57 %)
6 diff
(99.5 %id)
BU162258 eye, retinoblastoma NCAPH.a 75 to 1004 1 to 929       929/933
(99 %)
9 diff
(99.1 %id)
D38553   NCAPH.a 76 to 2801 1 to 2726 exact tiling clone, available from KIAA,   2726/2726
(100 %)
0 diff
(100 %id)
CN340543 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 77 to 708 1 to 632       632/632
(100 %)
1 diff
(99.9 %id)
BM556504 duodenal adenocarcinoma, cell line, small intestine NCAPH.a 79 to 680 1 to 608       608/991
(61 %)
6 diff
(99.4 %id)
CN340540 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 80 to 620 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AL524549 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized NCAPH.a 81 to 800 1 to 722       722/722
(100 %)
25 diff
(96.6 %id)
BI861182 breast, mammary adenocarcinoma, cell line NCAPH.a 84 to 836 1 to 754       754/754
(100 %)
1 diff
(99.9 %id)
TI_57192118   NCAPH.a 84 to 836 56 to 809       754/754
(100 %)
1 diff
(99.9 %id)
DR001104 fetal brain NCAPH.a 84 to 736 8 to 659       652/659
(98 %)
6 diff
(99.1 %id)
BG258991 embryonal carcinoma, cell line, testis NCAPH.a 85 to 818 1 to 736       736/752
(97 %)
15 diff
(98.1 %id)
BU182274 eye, retinoblastoma NCAPH.a 86 to 457 1 to 372       372/908
(40 %)
4 diff
(99.6 %id)
TI_1948218822   NCAPH.a 87 to 1001 122 to 1034       911/1337
(68 %)
30 diff
(97.8 %id)
TI_1948219073   NCAPH.a 87 to 679 123 to 717       595/1398
(42 %)
15 diff
(99.0 %id)
TI_1948219074   NCAPH.a 87 to 943 125 to 974       850/1314
(64 %)
42 diff
(96.9 %id)
TI_1948219318   NCAPH.a 87 to 817 119 to 849       731/1417
(51 %)
14 diff
(99.1 %id)
TI_1948219567   NCAPH.a 87 to 935 122 to 983       862/1425
(60 %)
34 diff
(97.7 %id)
DB145882 thymus NCAPH.a 89 to 632 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
BE538300 cervix NCAPH.a 90 to 764 1 to 683       664/801
(82 %)
36 diff
(95.6 %id)
CN340548 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 95 to 795 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
EL735164 mixed NCAPH.a 95 to 721 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
BQ961582 leiomyosarcoma, uterus NCAPH.a 97 to 870 1 to 784       782/821
(95 %)
12 diff
(98.6 %id)
CV814884 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass NCAPH.a 105 to 955 1 to 853       853/891
(95 %)
18 diff
(98.0 %id)
BP211161 cerebellum NCAPH.a 125 to 715 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BP354189   NCAPH.a 130 to 714 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BF981860 duodenal adenocarcinoma, cell line, small intestine NCAPH.a 144 to 826 53 to 728       676/768
(88 %)
24 diff
(96.9 %id)
AW408551 lymph NCAPH.a 146 to 499 8 to 361       352/361
(97 %)
6 diff
(98.4 %id)
TI_154148404   NCAPH.a 146 to 707 80 to 640       561/561
(100 %)
12 diff
(97.9 %id)
BG390762 embryonal carcinoma, cell line, testis NCAPH.a 147 to 813 1 to 667       667/672
(99 %)
6 diff
(99.2 %id)
AU128869   NCAPH.a 231 to 961 2 to 733   capped   732/734
(99 %)
12 diff
(98.4 %id)
BG108495 Bone, osteosarcoma, cell line NCAPH.a 245 to 1069 1 to 826       826/981
(84 %)
21 diff
(97.9 %id)
DA496327 brain NCAPH.a 259 to 820 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
AW407690 lymph NCAPH.a 361 to 664 1 to 304       304/304
(100 %)
4 diff
(98.7 %id)
BU171271 testis NCAPH.a 365 to 1162 1 to 805       803/810
(99 %)
22 diff
(97.3 %id)
TI_154146273   NCAPH.a 365 to 1004 80 to 716       637/674
(94 %)
13 diff
(98.1 %id)
BX431550 brain, fetal brain NCAPH.a 368 to 1004 1 to 633       633/911
(69 %)
19 diff
(98.0 %id)
BX431551 brain, fetal brain NCAPH.a 368 to 1004 1 to 624       624/883
(70 %)
29 diff
(96.8 %id)
DA474230   NCAPH.a 377 to 935 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
AW383801 head_neck NCAPH.a 393 to 681 7 to 295       289/295
(97 %)
9 diff
(97.0 %id)
BG286551 bladder, transitional cell papilloma, cell line NCAPH.a 423 to 1055 1 to 632       632/632
(100 %)
6 diff
(99.1 %id)
BE281222 choriocarcinoma, placenta NCAPH.a 470 to 1205 26 to 757       732/757
(96 %)
11 diff
(98.6 %id)
BX348995 Placenta Cot 25-normalized NCAPH.a 501 to 1419 1 to 916       916/963
(95 %)
35 diff
(96.4 %id)
CN340539 embryonic stem cells, DMSO-treated H9 cellline NCAPH.a 552 to 1069 1 to 518       518/518
(100 %)
5 diff
(99.1 %id)
DB120771 thymus NCAPH.a 647 to 1205 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AA314405 colon NCAPH.a 660 to 1203 1 to 543       543/543
(100 %)
2 diff
(99.7 %id)
AW361726 colon NCAPH.a 716 to 1230 11 to 523       513/523
(98 %)
8 diff
(98.5 %id)
BU189033 melanotic melanoma, cell line, skin NCAPH.a 720 to 1474 34 to 788       755/792
(95 %)
8 diff
(99.0 %id)
BU150166 melanotic melanoma, cell line, skin NCAPH.a 721 to 1473 1 to 753       753/755
(99 %)
2 diff
(99.8 %id)
BQ681744 melanotic melanoma, cell line, skin NCAPH.a 721 to 1306 1 to 587       587/1140
(51 %)
8 diff
(99.3 %id)
DA729385   NCAPH.a 722 to 1477 2 to 756   capped   755/757
(99 %)
5 diff
(99.4 %id)
BE868962 adenocarcinoma, colon NCAPH.a 753 to 1345 1 to 601       601/601
(100 %)
11 diff
(98.2 %id)
DB036660 testis NCAPH.a 761 to 1327 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CN340546 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 767 to 1476 1 to 710       710/710
(100 %)
0 diff
(100 %id)
BF747215 breast NCAPH.a 781 to 1094 376 to 64     Submitted on the opposite strand 311/376
(82 %)
2 diff
(99.5 %id)
AI564802 anaplastic oligodendroglioma, brain NCAPH.a 817 to 1477 665 to 1       665/703
(94 %)
18 diff
(97.5 %id)
AI655443 pooled germ cell tumors NCAPH.a 830 to 1477 648 to 1       648/648
(100 %)
2 diff
(99.7 %id)
BM453001 leiomyosarcoma, uterus NCAPH.a 881 to 1419 1 to 540       540/962
(56 %)
17 diff
(98.3 %id)
CK000295 mixed NCAPH.a 962 to 1684 8 to 730       723/761
(95 %)
10 diff
(98.7 %id)
AU124223   NCAPH.a 970 to 1742 2 to 777   capped   776/776
(100 %)
7 diff
(99.1 %id)
DA600627   NCAPH.a 977 to 1543 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
AA976954 pooled germ cell tumors NCAPH.a 986 to 1485 503 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 501/503
(99 %)
3 diff
(99.5 %id)
BU160102 leiomyosarcoma, uterus NCAPH.a 988 to 1690 1 to 706       706/902
(78 %)
14 diff
(98.5 %id)
CX872172 embryonic stem NCAPH.a 1034 to 1812 1 to 778       778/778
(100 %)
2 diff
(99.8 %id)
N54344 liver and spleen NCAPH.a 1046 to 1472 431 to 1       431/438
(98 %)
4 diff
(99.1 %id)
DW437808 Liver NCAPH.a 1056 to 1293 10 to 247       238/247
(96 %)
5 diff
(98.0 %id)
DW450917 Liver NCAPH.a 1056 to 1241 10 to 195       186/195
(95 %)
7 diff
(96.5 %id)
AA961770 pooled germ cell tumors NCAPH.a 1109 to 1477 369 to 1       369/484
(76 %)
1 diff
(99.8 %id)
AI962489 pooled germ cell tumors NCAPH.a 1109 to 1477 369 to 1       369/520
(70 %)
0 diff
(100 %id)
DR760427 embryonic stem NCAPH.a 1113 to 1914 1 to 801       801/801
(100 %)
1 diff
(99.9 %id)
CN340545 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 1122 to 1847 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
AI383226 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus NCAPH.a 1160 to 1475 316 to 1       316/316
(100 %)
13 diff
(95.9 %id)
BG030776 breast, mammary adenocarcinoma, cell line NCAPH.a 1222 to 1918 1 to 696       696/705
(98 %)
3 diff
(99.6 %id)
BX350228 Placenta Cot 25-normalized NCAPH.a 1228 to 2134 905 to 1       905/907
(99 %)
11 diff
(98.8 %id)
AW245187 lung, small cell carcinoma NCAPH.a 1295 to 1908 1 to 614       614/614
(100 %)
5 diff
(99.2 %id)
AW249167 lung, small cell carcinoma NCAPH.a 1295 to 1919 1 to 625       625/625
(100 %)
5 diff
(99.2 %id)
TI_57165712   NCAPH.a 1300 to 1952 90 to 743       654/743
(88 %)
9 diff
(98.8 %id)
H47527 liver and spleen NCAPH.a 1303 to 1683 10 to 402       393/440
(89 %)
21 diff
(95.3 %id)
TI_1948219076   NCAPH.a 1303 to 2319 1148 to 126       1023/1270
(80 %)
44 diff
(96.6 %id)
BY797679 eye NCAPH.a 1306 to 1372 1 to 67       67/67
(100 %)
0 diff
(100 %id)
BF970861 adrenal cortex carcinoma, cell line, adrenal gland NCAPH.a 1335 to 1977 1 to 638       638/1080
(59 %)
9 diff
(99.2 %id)
TI_1948219075   NCAPH.a 1339 to 2319 1102 to 123       980/1280
(76 %)
33 diff
(97.5 %id)
BG027108 Bone, osteosarcoma, cell line NCAPH.a 1340 to 2080 1 to 740       740/936
(79 %)
13 diff
(98.7 %id)
TI_1948218823   NCAPH.a 1364 to 2319 1090 to 127       964/1308
(73 %)
24 diff
(98.2 %id)
TI_1948218824   NCAPH.a 1452 to 2319 1003 to 132       872/1297
(67 %)
14 diff
(99.0 %id)
TI_1948219568   NCAPH.a 1452 to 2319 995 to 125       871/1313
(66 %)
12 diff
(99.1 %id)
TI_1948219319   NCAPH.a 1454 to 2319 989 to 123       867/1299
(66 %)
9 diff
(99.4 %id)
TI_1948219320   NCAPH.a 1550 to 2319 894 to 127       768/1264
(60 %)
8 diff
(99.4 %id)
BF216895 brain, glioblastoma NCAPH.a 1577 to 2184 1 to 599       599/645
(92 %)
19 diff
(97.1 %id)
BM468688 duodenal adenocarcinoma, cell line, small intestine NCAPH.a 1679 to 2621 1 to 946       946/950
(99 %)
14 diff
(98.6 %id)
BE674548 carcinoid, lung NCAPH.a 1762 to 2287 1 to 526     Submitted on the opposite strand 526/526
(100 %)
5 diff
(99.1 %id)
AI268885 carcinoid, lung NCAPH.a 1781 to 2240 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
BX399368 Placenta Cot 25-normalized NCAPH.a 1820 to 2776 953 to 9       945/964
(98 %)
14 diff
(98.6 %id)
DA902511   NCAPH.a 1831 to 2399 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BU941237 mixed (pool of 40 RNAs) NCAPH.a 1833 to 2745 1 to 922       922/943
(97 %)
53 diff
(94.4 %id)
BM721698 eye, fetal eye NCAPH.a 1851 to 2260 1 to 410       410/415
(98 %)
7 diff
(98.4 %id)
BG031316 breast, mammary adenocarcinoma, cell line NCAPH.a 1879 to 2618 1 to 743       743/874
(85 %)
14 diff
(98.4 %id)
AL120899 melanoma (MeWo cell line) NCAPH.a 1910 to 2379 1 to 470       470/470
(100 %)
0 diff
(100 %id)
CN340550 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.a 1938 to 2546 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BF355796 head_neck NCAPH.a 1942 to 2101 186 to 27       164/186
(88 %)
0 diff
(100 %id)
BI089593 cervix NCAPH.a 1960 to 2769 1 to 811       809/815
(99 %)
16 diff
(98.1 %id)
BE877319 large cell carcinoma, undifferentiated, lung NCAPH.a 1974 to 2716 1 to 738   AAA   738/810
(91 %)
7 diff
(99.2 %id)
BI061948 uterus_tumor NCAPH.a 2008 to 2479 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AW008228 poorly differentiated adenocarcinoma withsignet ring cell features, stomach NCAPH.a 2010 to 2800 796 to 1       796/796
(100 %)
22 diff
(97.3 %id)
BP421975 small intestine NCAPH.a 2013 to 2549 1 to 537     Submitted on the opposite strand 537/537
(100 %)
0 diff
(100 %id)
AA411963.
matches multiple genes
  NCAPH.a 2014 to 2071 1 to 58     also hits gene APCandSRP19andZRSR1 58/58
(100 %)
0 diff
(100 %id)
BQ014135 Chondrosarcoma, Left Pubic Bone NCAPH.a 2058 to 2801 760 to 17   AAA   744/744
(100 %)
1 diff
(99.9 %id)
CN340541 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 NCAPH.a 2077 to 2586 1 to 511       511/511
(100 %)
6 diff
(98.9 %id)
TI_149288469   NCAPH.a 2128 to 2808 771 to 93   AAA   679/679
(100 %)
2 diff
(99.8 %id)
AW249643 lung, small cell carcinoma NCAPH.a 2135 to 2799 675 to 11   AAA   665/665
(100 %)
1 diff
(99.9 %id)
CA423478 cell lines, Chondrosarcoma NCAPH.a 2138 to 2808 688 to 19   AAA   670/672
(99 %)
1 diff
(99.9 %id)
CA419375 Bone, Human Chondrosarcoma Cell Line NCAPH.a 2138 to 2799 677 to 16   AAA   662/662
(100 %)
0 diff
(100 %id)
AA767285 germinal center B cell NCAPH.a 2150 to 2685 536 to 1       536/536
(100 %)
8 diff
(98.6 %id)
AA282399 germinal center B cell NCAPH.a 2152 to 2493 1 to 341       341/341
(100 %)
1 diff
(99.8 %id)
BM970326 lung NCAPH.a 2153 to 2808 674 to 19   AAA   656/658
(99 %)
0 diff
(100 %id)
BG939151 Bone, Hip NCAPH.a 2183 to 2778 603 to 8       596/603
(98 %)
0 diff
(100 %id)
AA808892 germinal center B-cells, tonsil NCAPH.a 2195 to 2803 613 to 5       609/613
(99 %)
0 diff
(100 %id)
AU153399   NCAPH.a 2224 to 2808 582 to 1       582/583
(99 %)
12 diff
(98.0 %id)
BF513300   NCAPH.a 2225 to 2808 601 to 18   AAA   584/584
(100 %)
0 diff
(100 %id)
AW248740 lung, small cell carcinoma NCAPH.a 2226 to 2799 590 to 11   AAA   580/580
(100 %)
4 diff
(99.4 %id)
BQ187495 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid NCAPH.a 2233 to 2801 1 to 569   AAA   569/569
(100 %)
0 diff
(100 %id)
TI_158431316   NCAPH.a 2259 to 2799 641 to 95   AAA   547/848
(64 %)
36 diff
(95.8 %id)
DB324418   NCAPH.a 2274 to 2813 539 to 1       539/539
(100 %)
19 diff
(96.5 %id)
AU151093   NCAPH.a 2291 to 2808 518 to 1       518/576
(89 %)
9 diff
(98.5 %id)
R07675 liver and spleen NCAPH.a 2311 to 2566 6 to 263   fully sequenced,   258/263
(98 %)
8 diff
(97.0 %id)
AA197285.
matches multiple genes
  NCAPH.a 2312 to 2808 495 to 1     also hits gene USP25 495/496
(99 %)
2 diff
(99.6 %id)
AW138009   NCAPH.a 2335 to 2808 491 to 18   AAA   474/474
(100 %)
2 diff
(99.6 %id)
AA342415 Spleen NCAPH.a 2341 to 2631 1 to 293       293/299
(97 %)
2 diff
(99.4 %id)
AA807611 germinal center B cell NCAPH.a 2348 to 2813 474 to 12   AAA   463/463
(100 %)
6 diff
(98.8 %id)
BU182832 melanotic melanoma, skin NCAPH.a 2348 to 2799 1 to 452   AAA   452/452
(100 %)
5 diff
(98.9 %id)
AA836999 Kidney, kidney tumor NCAPH.a 2350 to 2813 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
BG390980 embryonal carcinoma, cell line, testis NCAPH.a 2352 to 2808 1 to 457   AAA   457/457
(100 %)
0 diff
(100 %id)
DB517127 testis NCAPH.a 2362 to 2799 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
BF871723 lung_tumor NCAPH.a 2370 to 2566 198 to 2     Submitted on the opposite strand 197/198
(99 %)
0 diff
(100 %id)
BF871983 lung_tumor NCAPH.a 2370 to 2567 198 to 1     Submitted on the opposite strand 198/198
(100 %)
4 diff
(98.0 %id)
DB516688 testis NCAPH.a 2371 to 2808 1 to 438     Submitted on the opposite strand 438/438
(100 %)
4 diff
(99.1 %id)
DB523633 testis NCAPH.a 2374 to 2808 1 to 435     Submitted on the opposite strand 435/435
(100 %)
3 diff
(99.4 %id)
AI673738 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus NCAPH.a 2384 to 2803 424 to 5       420/424
(99 %)
0 diff
(100 %id)
DB508685 testis NCAPH.a 2391 to 2808 1 to 419     Submitted on the opposite strand 419/419
(100 %)
26 diff
(93.8 %id)
BE208061 Kidney, renal cell adenocarcinoma NCAPH.a 2392 to 2811 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BM151402 leukopheresis NCAPH.a 2399 to 2803 416 to 13       404/425
(95 %)
0 diff
(100 %id)
CR610329 Neuroblastoma Cot 25-normalized NCAPH.a 2406 to 2805 1 to 400       400/400
(100 %)
0 diff
(100 %id)
BX374791 Neuroblastoma Cot 25-normalized NCAPH.a 2406 to 2805 1 to 400       400/400
(100 %)
4 diff
(99.0 %id)
AI699805 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors NCAPH.a 2421 to 2800 381 to 2       380/381
(99 %)
0 diff
(100 %id)
AA713690 germinal center B cell NCAPH.a 2423 to 2685 263 to 1       263/263
(100 %)
0 diff
(100 %id)
AI025246   NCAPH.a 2423 to 2800 380 to 3       378/380
(99 %)
0 diff
(100 %id)
DB322077   NCAPH.a 2428 to 2808 382 to 1       382/388
(98 %)
4 diff
(99.0 %id)
BM677290 eye, fetal eye NCAPH.a 2433 to 2808 394 to 19   AAA   376/376
(100 %)
1 diff
(99.8 %id)
AW079231 colon, juvenile granulosa tumor NCAPH.a 2438 to 2799 362 to 1       362/362
(100 %)
0 diff
(100 %id)
AA743549 germinal center B cell NCAPH.a 2457 to 2799 356 to 15   AAA   342/342
(100 %)
1 diff
(99.8 %id)
AA910918 carcinoid, lung NCAPH.a 2457 to 2798 340 to 1       340/340
(100 %)
6 diff
(98.3 %id)
CB160726 Liver NCAPH.a 2464 to 2769 5 to 310       306/310
(98 %)
6 diff
(98.1 %id)
AI220961 placenta NCAPH.a 2469 to 2799 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AI498105 anaplastic oligodendroglioma, brain NCAPH.a 2479 to 2800 324 to 3       322/332
(96 %)
0 diff
(100 %id)
CF528582 placenta NCAPH.a 2481 to 2799 336 to 18   AAA   319/319
(100 %)
6 diff
(98.2 %id)
AI360082 anaplastic oligodendroglioma, brain NCAPH.a 2512 to 2800 290 to 2       289/290
(99 %)
0 diff
(100 %id)
R07629 liver and spleen NCAPH.a 2536 to 2793 257 to 1   fully sequenced,   257/257
(100 %)
1 diff
(99.7 %id)
DB510091 testis NCAPH.a 2558 to 2801 1 to 242     Submitted on the opposite strand 242/242
(100 %)
9 diff
(96.3 %id)
AA282057 germinal center B cell NCAPH.a 2594 to 2808 215 to 1       215/215
(100 %)
3 diff
(98.7 %id)
AA306111   NCAPH.a 2640 to 3125 10 to 495   tiling clone,   486/495
(98 %)
6 diff
(98.8 %id)
AW953555   NCAPH.a 2640 to 3276 9 to 645   tiling clone,   637/645
(98 %)
6 diff
(99.1 %id)
AI802280   NCAPH.a 2697 to 2808 112 to 1       112/112
(100 %)
0 diff
(100 %id)
BE537202 cervix NCAPH.a 2817 to 3606 1 to 803   tiling clone,   803/853
(94 %)
41 diff
(95.2 %id)
AW978614   NCAPH.a 3497 to 4181 686 to 1   tiling clone, Submitted on the opposite strand 686/686
(100 %)
15 diff
(97.9 %id)
DR762758 embryonic stem NCAPH.a 3593 to 4101 10 to 516       507/516
(98 %)
6 diff
(98.9 %id)
AL553673 placenta, Placenta Cot 25-normalized NCAPH.a 3633 to 4500 1 to 868   tiling clone,   868/872
(99 %)
1 diff
(99.9 %id)
AA836426 germinal center B cell NCAPH.a 3751 to 4118 368 to 1       368/368
(100 %)
2 diff
(99.5 %id)
CR592757 Placenta Cot 25-normalized NCAPH.b 1 to 2952 1 to 2952 exact tiling clone,   2952/2952
(100 %)
0 diff
(100 %id)
BX399369 Placenta Cot 25-normalized NCAPH.b 1 to 975 1 to 959       959/959
(100 %)
19 diff
(98.1 %id)
BM152381 leukopheresis NCAPH.c 1 to 509 1 to 509   tiling clone,   509/513
(99 %)
11 diff
(97.9 %id)
BG717173 testis NCAPH.c 29 to 740 1 to 712       712/713
(99 %)
4 diff
(99.5 %id)
BQ882507 brain, neuroblastoma, cell line NCAPH.c 36 to 954 1 to 919       919/919
(100 %)
6 diff
(99.4 %id)
AK299248   NCAPH.c 56 to 2462 1 to 2407 V515A tiling clone,   2407/2407
(100 %)
3 diff
(99.9 %id)
DC371531   NCAPH.c 56 to 629 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
BM754358 stomach NCAPH.c 56 to 564 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
BM006317 ductal carcinoma, cell line, Pancreas NCAPH.d 1 to 610 6 to 624       624/780
(80 %)
15 diff
(98.1 %id)
BM006534 ductal carcinoma, cell line, Pancreas NCAPH.d 1 to 724 6 to 739   tiling clone,   739/959
(77 %)
18 diff
(98.2 %id)
TI_59394953   NCAPH.d 1 to 610 115 to 733       623/779
(79 %)
14 diff
(98.3 %id)
TI_59395601   NCAPH.d 1 to 724 108 to 841       738/958
(77 %)
17 diff
(98.3 %id)
BQ878773 ductal carcinoma, cell line, Pancreas NCAPH.d 1 to 322 4 to 325       325/330
(98 %)
3 diff
(99.1 %id)
BQ876685 ductal carcinoma, cell line, Pancreas NCAPH.d 1 to 822 4 to 837   tiling clone,   797/899
(88 %)
15 diff
(98.4 %id)
BU149259 ductal carcinoma, cell line, Pancreas NCAPH.d 1 to 687 4 to 692       692/977
(70 %)
12 diff
(98.8 %id)
BQ901136 ductal carcinoma, cell line, Pancreas NCAPH.d 1 to 617 4 to 622       622/996
(62 %)
9 diff
(99.1 %id)
BP353928   NCAPH.d 8 to 588 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DC361022   NCAPH.d 16 to 576 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DA029021   NCAPH.d 21 to 592 2 to 578   capped   577/577
(100 %)
5 diff
(99.2 %id)
DC357675   NCAPH.d 26 to 592 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
DC386221   NCAPH.d 26 to 576 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
DC297842   NCAPH.d 27 to 589 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
DC346387 tongue, tumor tissue NCAPH.d 27 to 612 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DC347073 tongue, tumor tissue NCAPH.d 27 to 582 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DC350142 brain NCAPH.d 27 to 597 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC360026   NCAPH.d 27 to 586 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC361244   NCAPH.d 27 to 604 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
CB111611 Liver NCAPH.d 27 to 500 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
CB113163 Liver NCAPH.d 27 to 559 1 to 533       533/533
(100 %)
0 diff
(100 %id)
DC428311   NCAPH.d 27 to 612 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
DC428412   NCAPH.d 27 to 608 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC371098   NCAPH.d 27 to 591 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC386292   NCAPH.d 27 to 600 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BF984232 duodenal adenocarcinoma, cell line, small intestine NCAPH.d 39 to 602 1 to 568       568/732
(77 %)
7 diff
(99.1 %id)
AA174038   NCAPH.d 40 to 614 1 to 575       575/623
(92 %)
18 diff
(97.2 %id)
AA206987   NCAPH.d 44 to 617 1 to 583       583/595
(97 %)
17 diff
(97.2 %id)
CN355526 embryonic stem cells, DMSO-treated H9 cellline NCAPH.d 46 to 196 1 to 151       151/151
(100 %)
1 diff
(99.4 %id)
AU127960   NCAPH.d 72 to 549 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
BM007260 ductal carcinoma, cell line, Pancreas NCAPH.d 690 to 1335 677 to 20   tiling clone,   658/677
(97 %)
19 diff
(97.2 %id)
TI_59394954   NCAPH.d 690 to 1335 677 to 20       658/677
(97 %)
19 diff
(97.2 %id)
BM007083 ductal carcinoma, cell line, Pancreas NCAPH.d 795 to 1345 570 to 16   tiling clone,   555/570
(97 %)
12 diff
(97.9 %id)
TI_59395602   NCAPH.d 795 to 1345 570 to 16       555/570
(97 %)
12 diff
(97.9 %id)
BX118893 liver and spleen NCAPH.d 1231 to 1990 8 to 768   tiling clone,   761/772
(98 %)
9 diff
(98.9 %id)
CX787634 human embryonic stem cells NCAPH.d 1586 to 2387 1 to 802   tiling clone,   802/804
(99 %)
2 diff
(99.8 %id)
AA173036   NCAPH.d 1968 to 2634 655 to 1   tiling clone,   657/662
(99 %)
22 diff
(96.7 %id)
DB365058   NCAPH.d 2094 to 2643 550 to 1   tiling clone,   550/603
(91 %)
9 diff
(98.6 %id)
AK303725 kidney, tumor tissue NCAPH.e 1 to 2363 1 to 2363 exact tiling clone,   2363/2363
(100 %)
0 diff
(100 %id)
DC412283 kidney, tumor tissue NCAPH.e 1 to 536 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BP363235 lung NCAPH.f 1 to 574 1 to 574   tiling clone,   574/582
(98 %)
4 diff
(99.4 %id)
AV761831 bone marrow NCAPH.f 7 to 634 1 to 622       629/645
(97 %)
67 diff
(89.7 %id)
DC427909   NCAPH.f 24 to 608 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BP201986 amygdala NCAPH.f 26 to 608 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC407656 thymus NCAPH.f 26 to 578 1 to 553       553/553
(100 %)
0 diff
(100 %id)
DC348519   NCAPH.f 29 to 585 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BM006670 ductal carcinoma, cell line, Pancreas NCAPH.f 30 to 918 1 to 885       885/917
(96 %)
14 diff
(98.5 %id)
BU157669 ductal carcinoma, cell line, Pancreas NCAPH.f 30 to 773 1 to 750       750/939
(79 %)
11 diff
(98.9 %id)
DB458150 testis NCAPH.f 31 to 530 1 to 500       500/500
(100 %)
0 diff
(100 %id)
TI_59395449   NCAPH.f 31 to 918 96 to 979       884/916
(96 %)
13 diff
(98.6 %id)
BU185174 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 966 1 to 941   AAA   941/1063
(88 %)
30 diff
(97.2 %id)
BU157322 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 966 1 to 938       938/1036
(90 %)
15 diff
(98.6 %id)
BU185219 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 1046 1 to 1027       952/1027
(92 %)
21 diff
(98.0 %id)
BU174109 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 921 1 to 894       894/1066
(83 %)
27 diff
(97.5 %id)
BU163090 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 772 1 to 740       740/880
(84 %)
11 diff
(98.8 %id)
BU196656 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 824 1 to 801       799/908
(87 %)
11 diff
(98.8 %id)
BU169085 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 776 1 to 748       748/895
(83 %)
4 diff
(99.6 %id)
BU157863 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 820 1 to 797       795/931
(85 %)
23 diff
(97.6 %id)
BU185885 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 913 1 to 887       887/888
(99 %)
17 diff
(98.1 %id)
BU180407 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 903 1 to 877       877/878
(99 %)
7 diff
(99.3 %id)
BQ879734 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 774 1 to 750       750/912
(82 %)
19 diff
(98.0 %id)
BU185416 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 920 1 to 894       894/898
(99 %)
20 diff
(97.8 %id)
BU174522 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 965 1 to 945       945/1005
(94 %)
19 diff
(98.2 %id)
BU163449 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 966 1 to 937   tiling clone,   937/973
(96 %)
6 diff
(99.4 %id)
BU163407 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 890 1 to 868       868/887
(97 %)
11 diff
(98.8 %id)
BQ879243 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 918 1 to 896       895/896
(99 %)
34 diff
(96.3 %id)
BQ685302 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 831 1 to 801       801/867
(92 %)
12 diff
(98.7 %id)
BQ691965 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 875 1 to 851       851/854
(99 %)
10 diff
(98.9 %id)
BQ691906 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 932 1 to 904       904/904
(100 %)
14 diff
(98.5 %id)
BQ687400 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 900 1 to 877       877/879
(99 %)
10 diff
(98.9 %id)
BQ685570 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 852 1 to 831       831/890
(93 %)
15 diff
(98.4 %id)
BQ689854 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 897 1 to 868       868/868
(100 %)
4 diff
(99.6 %id)
BQ689107 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 908 1 to 879       879/879
(100 %)
11 diff
(98.8 %id)
BQ685467 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 991 1 to 963       963/963
(100 %)
12 diff
(98.8 %id)
BQ691959 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 887 1 to 862       862/864
(99 %)
14 diff
(98.4 %id)
BQ888477 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 870 1 to 848       845/928
(91 %)
27 diff
(97.1 %id)
BQ690837 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 904 1 to 875       874/875
(99 %)
16 diff
(98.2 %id)
BQ687347 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 900 1 to 874       874/874
(100 %)
6 diff
(99.4 %id)
BQ690930 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 912 1 to 884       884/884
(100 %)
3 diff
(99.7 %id)
BQ688492 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 929 1 to 908       908/932
(97 %)
19 diff
(98.0 %id)
BQ691466 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 834 1 to 810       810/834
(97 %)
9 diff
(99.0 %id)
BQ691275 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 891 1 to 867       867/869
(99 %)
8 diff
(99.1 %id)
BQ876589 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 774 1 to 746       746/944
(79 %)
21 diff
(97.8 %id)
BQ901040 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 775 1 to 745       745/961
(77 %)
13 diff
(98.7 %id)
BQ689458 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 965 1 to 943       943/944
(99 %)
16 diff
(98.4 %id)
BQ689672 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 940 1 to 911       911/924
(98 %)
5 diff
(99.5 %id)
BQ689571 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 915 1 to 892       892/895
(99 %)
12 diff
(98.7 %id)
BQ689336 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 879 1 to 858       858/922
(93 %)
14 diff
(98.5 %id)
BQ691168 ductal carcinoma, cell line, Pancreas NCAPH.f 32 to 767 1 to 738       738/938
(78 %)
27 diff
(97.2 %id)
DC422974 uterus NCAPH.f 42 to 590 1 to 549       549/549
(100 %)
0 diff
(100 %id)
AK308050   NCAPH.f 61 to 1912 1 to 1853 S348G V569C P571T V572C G573W ... tiling clone,   1853/1853
(100 %)
3 diff
(99.9 %id)
BE782506 eye, retinoblastoma NCAPH.f 61 to 818 1 to 758       762/759
(100 %)
26 diff
(96.6 %id)
CN340551 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.f 63 to 776 7 to 722       716/725
(98 %)
9 diff
(98.8 %id)
BM541365 leiomyosarcoma, uterus NCAPH.f 72 to 1066 1 to 996       996/1084
(91 %)
25 diff
(97.7 %id)
CR620375 Neuroblastoma Cot 25-normalized NCAPH.g 1 to 1889 1 to 1889 exact tiling clone,   1889/1889
(100 %)
0 diff
(100 %id)
AK310649 thymus NCAPH.h 1 to 1573 1 to 1573   tiling clone,   1573/1573
(100 %)
1 diff
(100.0 %id)
DC408424 thymus NCAPH.h 1 to 523 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
BF540721 hypernephroma, Kidney NCAPH.i 1 to 674 1 to 677       677/808
(83 %)
29 diff
(96.5 %id)
BF540742 hypernephroma, Kidney NCAPH.i 1 to 576 1 to 577       577/605
(95 %)
9 diff
(98.6 %id)
BF695524 brain, primitive neuroectoderm NCAPH.i 1 to 710 1 to 709       707/730
(96 %)
18 diff
(97.6 %id)
BF695532 brain, primitive neuroectoderm NCAPH.i 1 to 673 1 to 672       672/724
(92 %)
13 diff
(98.3 %id)
BF695539 brain, primitive neuroectoderm NCAPH.i 1 to 702 1 to 696       696/890
(78 %)
19 diff
(97.9 %id)
BF695823 brain, primitive neuroectoderm NCAPH.i 1 to 576 1 to 581       581/584
(99 %)
11 diff
(98.2 %id)
BF669105 brain, primitive neuroectoderm NCAPH.i 1 to 576 1 to 575   tiling clone,   575/872
(65 %)
8 diff
(99.1 %id)
BF246629 brain, glioblastoma NCAPH.i 2 to 673 1 to 661       661/838
(78 %)
39 diff
(95.4 %id)
BF695940 brain, primitive neuroectoderm NCAPH.i 2 to 676 1 to 675       675/841
(80 %)
27 diff
(96.8 %id)
BF695501 brain, primitive neuroectoderm NCAPH.i 2 to 673 1 to 666       666/874
(76 %)
13 diff
(98.6 %id)
BF695565 brain, primitive neuroectoderm NCAPH.i 2 to 576 1 to 574       574/856
(67 %)
8 diff
(99.1 %id)
BF695659 brain, primitive neuroectoderm NCAPH.i 2 to 648 1 to 641       641/645
(99 %)
38 diff
(94.2 %id)
BF695696 brain, primitive neuroectoderm NCAPH.i 2 to 673 1 to 675       673/848
(79 %)
33 diff
(96.2 %id)
BF700933 brain, primitive neuroectoderm NCAPH.i 2 to 676 1 to 675       675/798
(84 %)
32 diff
(96.0 %id)
AW372047 breast NCAPH.i 230 to 808 7 to 586   tiling clone,   578/589
(98 %)
12 diff
(98.0 %id)
BE065765 breast NCAPH.i 240 to 740 1 to 502       500/502
(99 %)
15 diff
(97.1 %id)
CN340544 embryonic stem cells, cell lines H1, H7, andH9 NCAPH.i 595 to 1131 17 to 554   tiling clone,   538/554
(97 %)
9 diff
(98.4 %id)
BI837500 pooled pancreas and spleen NCAPH.j 1 to 705 1 to 709 T2M R3T E4T E5A M6E ... tiling clone,   709/709
(100 %)
7 diff
(99.1 %id)
DA506519 brain NCAPH.k-u 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
CR608905 Placenta Cot 25-normalized NCAPH.k-u 91 to 2494 1 to 2404 exact tiling clone,   2404/2404
(100 %)
0 diff
(100 %id)
BU175743 embryonal carcinoma, cell line, testis NCAPH.k-u 400 to 1215 1 to 828       828/873
(94 %)
27 diff
(97.0 %id)
BX350240 Placenta Cot 25-normalized NCAPH.k-u 806 to 1724 918 to 1       918/921
(99 %)
14 diff
(98.5 %id)
BX327360 Placenta Cot 25-normalized NCAPH.k-u 842 to 1767 1 to 925       925/930
(99 %)
13 diff
(98.7 %id)
BG391309 embryonal carcinoma, cell line, testis NCAPH.k-u 1369 to 2137 1 to 771       771/771
(100 %)
7 diff
(99.1 %id)
AL576598 placenta, Placenta Cot 25-normalized NCAPH.k-u 1573 to 2494 926 to 1 A5X S9X L26Y V27G H28S ...     926/926
(100 %)
8 diff
(99.2 %id)
BX096707 heart NCAPH.k-u 1579 to 2237 1 to 661       661/661
(100 %)
2 diff
(99.7 %id)
CB123155 Liver NCAPH.k-u 1786 to 2087 1 to 302       302/302
(100 %)
0 diff
(100 %id)
DB316107 brain NCAPH.k-u 1962 to 2507 546 to 1 exact     546/546
(100 %)
0 diff
(100 %id)
AI130899 heart NCAPH.k-u 2070 to 2522 458 to 6 exact tiling clone,   453/458
(98 %)
0 diff
(100 %id)
FN057535 breast carcinoma NCAPH.k-u 2182 to 2257 1 to 76       76/79
(96 %)
2 diff
(97.5 %id)
BM804779 ovary (pool of 3) NCAPH.l-u 1 to 845 138 to 997 L85M tiling clone,   860/1157
(74 %)
23 diff
(98.1 %id)
BM804722 ovary (pool of 3) NCAPH.l-u 2 to 963 1 to 956 L85M tiling clone,   956/956
(100 %)
13 diff
(98.7 %id)
BI094811 bone marrow NCAPH.m-u 1 to 280 295 to 16 P3L tiling clone, AAA   280/280
(100 %)
2 diff
(99.3 %id)
AL523769 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene NCAPH, variant not shown         Suspected internal deletion, this clone was ignored    
AL562259 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene NCAPH, variant not shown         Suspected internal deletion, this clone was ignored    
DB314306 tongue, tumor tissue Gene NCAPH, variant not shown         This clone was ignored    
DA454283 tongue, tumor tissue Gene NCAPH, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI